Alkahest, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2014-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.alkahest.com
Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration
- First Posted Date
- 2018-06-15
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Alkahest, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT03558074
- Locations
- 🇭🇺
Jahn Ferenc South-Pest Hospital and Clinic, Budapest, Hungary
🇭🇺Markusovszky University Teaching Hospital, Szombathely, Hungary
🇭🇺Borsod-Abauj-Zemplen County Hospital and Teaching Hospital, Miskolc, Hungary
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2
Completed
- Conditions
- Mild to Moderate Alzheimer DiseaseAlzheimer Disease
- Interventions
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Alkahest, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT03520998
- Locations
- 🇺🇸
Princeton Medical Institute, Princeton, New Jersey, United States
🇺🇸CNS Network, Long Beach, California, United States
🇺🇸Synergy East, Lemon Grove, California, United States
© Copyright 2025. All Rights Reserved by MedPath